Mark L. Rosenblum
- Genetics top 0.1%
- Surgery top 1%
- Molecular Biology top 5%
- Epidemiology top 1%
- Oncology top 2%
- Co-authors
- Robert M. LevyDale E. BredesenJack RockTom MikkelsenJames T. RutkaSamuel RyuCharles B. WilsonJae Ho Kim
- Topics
- Glioma Diagnosis and Treatment (58 papers)Meningioma and schwannoma management (18 papers)Brain Metastases and Treatment (17 papers)
- Cited by
- MicrobiologyGeneticsVirology
- Partner nations
- United StatesItalyCanada
In The Last Decade
Mark L. Rosenblum
200 papers receiving 10.4k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Genetics 2.7k
- Surgery 2.3k
- Molecular Biology 2.2k
- Epidemiology 1.9k
- Oncology 1.6k
Countries citing papers authored by Mark L. Rosenblum
This map shows the geographic impact of Mark L. Rosenblum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Rosenblum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Rosenblum more than expected).
Fields of papers citing papers by Mark L. Rosenblum
This network shows the impact of papers produced by Mark L. Rosenblum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Rosenblum. The network helps show where Mark L. Rosenblum may publish in the future.
Co-authorship network of co-authors of Mark L. Rosenblum
This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Rosenblum. A scholar is included among the top collaborators of Mark L. Rosenblum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Rosenblum. Mark L. Rosenblum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 62 | |
| 2 | 35 | |
| 3 | 4 | |
| 4 | 58 | |
| 5 | 50 | |
| 6 | 13 | |
| 7 | 144 | |
| 8 | 166 | |
| 9 | The practical management of low-grade primary brain tumors | 23 |
| 10 | 47 | |
| 11 | Clonal expansion of p53 mutant cells is associated with brain tumour progressionbreakdown → | 578 |
| 12 | 3 | |
| 13 | 1 | |
| 14 | Neuroepidemiology of acquired immunodeficiency syndrome. | 47 |
| 15 | 2 | |
| 16 | 81 | |
| 17 | 3 | |
| 18 | Evidence for rearrangement and amplification of the c-myc cellular oncogene in a human glioblastoma | 5 |
| 19 | 27 | |
| 20 | Analysis of clonogenic human brain tumour cells: preliminary results of tumour sensitivity testing with BCNU. | 4 |
About Mark L. Rosenblum
Mark L. Rosenblum is a scholar working on Microbiology, Genetics and Neurology, having authored 210 papers that have together received 10.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (58 papers), Meningioma and schwannoma management (18 papers) and Brain Metastases and Treatment (17 papers). The work is most often cited by research in Microbiology (278 citations), Genetics (2.7k citations) and Virology (920 citations). Mark L. Rosenblum has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Robert M. Levy, Dale E. Bredesen, Jack Rock, Tom Mikkelsen, James T. Rutka, Samuel Ryu, Charles B. Wilson, Jae Ho Kim, Thomas J. Mampalam and K. Schwechheimer. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.